ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced the addition of independent board member Sachin H. Jain, MD, MBA. Dr. Jain is currently President and Chief Executive Officer […]

Conference Call Scheduled for Today, November 4, 2020, at 3:30 PM CT (4:30 PM ET) Revenues of $60.5 million increased 42% sequentially and decreased 6.1% compared to last year Net loss was $2.1 million, or $0.05 per basic and diluted share Management provides fiscal 2021 second quarter revenue guidance of […]

ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that the underwriters of its recent public offering of common stock have fully exercised their option resulting in the issuance […]

Conference Call Scheduled for Today, February 5, 2020, at 3:30 PM CT (4:30 PM ET) Revenues of $68.3 million increased 13.5% from second quarter last year Net loss was $3.4 million, or $0.10 per basic and diluted share Company raises low end of fiscal 2020 revenue guidance range ST. PAUL, […]